Julie Shea, NP
Adult Health · Boston, MANPI 1770658254
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 96.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $2,547 and has fallen 57.0% since, to $1,095 in 2025. Among adult health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $150.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Boston Scientific$168
- Bridgebio Pharma, Inc.$113
What the payments were for
- Speaking & faculty fees$3,12542%
- Travel & lodging$1,87626%
- Food & beverage$2,35432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 46 | $7,073 |
| Boston Scientific | 2 | $168 |
| Bridgebio Pharma, Inc. | 1 | $113 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$885
- EMBLEM MRI S-ICD$151
- Attruby$113
How this compares
$7,354 in reported general payments places this provider in the 95th percentile of 671 adult health providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 49 | $67,835 |
| XareltoRivaroxaban | 25 | $28,043 |
| Metoprolol Succinate | 157 | $3,084 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $2,029 |
| Nadolol | 11 | $1,428 |
| Amiodarone Hcl | 40 | $661 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $632 |
| Flecainide Acetate | 15 | $533 |
| SotalolSotalol Hcl | 20 | $393 |
Paid to pharmacies, not to this prescriber.
Other adult health in Boston
- Krista TuckerBoston$157K
- Christine AgiusBoston$32K
- Josie BazemoreBoston$22K
- Kathryn SchochBoston$11K
- Megan MaysBoston$8K
- Bonnie DirrBoston$8K
- Elyse MandellBoston$7K
- Sarah KennedyBoston$6K
- Virginia SeeryBoston$5K
- Ashton FrullaBoston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.